AVEN antibody (N-Term)

Catalog No. ABIN1881095

There are 3+ publications for this product available. The Rabbit Polyclonal anti-AVEN antibody is suitable to detect AVEN in samples from Human. It has been validated for WB.

Quick Overview for AVEN antibody (N-Term) (ABIN1881095)

Target: AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AVEN antibody is un-conjugated

Application: Western Blotting (WB)

Clone: RB41905

Product Details anti-AVEN Antibody

Binding Specificity: AA 78-106, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This AVEN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-106 amino acids from the N-terminal region of human AVEN.

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Expiry Date: 6 months

References for anti-AVEN antibody (ABIN1881095)

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" in: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, (2010) (PubMed).

Sugarbaker, Richards, Gordon, Dong, De Rienzo, Maulik, Glickman, Chirieac, Hartman, Taillon, Du, Bouffard, Kingsmore, Miller, Farmer, Jensen, Gullans, Bueno: "Transcriptome sequencing of malignant pleural mesothelioma tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 9, pp. 3521-6, (2008) (PubMed).

Target Details for AVEN

Target: AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))

Alternative Name: AVEN

Background: AVEN protects against apoptosis mediated by Apaf-1.

NCBI Accession: NP_065104

UniProt: Q9NQS1